Nitric Oxide Production in Human Macrophagic Cells Phagocytizing Opsonized Zymosan: Direct Characterization by Measurement of the Luminol Dependent Chemilurninescence

References

• Pick E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods in Enzymology 1986; 132: 407–421
   PubMedGoogle Scholar
• Granger D., Hibbs J. J., Perfect J., Durack D. Specific amino acid (L‐arginine) requirement for the microbiostatic activity of murine macrophages. Journal of Clinical Investigation 1988; 81: 1129–1136
   PubMed Web of Science ®Google Scholar
• Denis M. Interferon y‐treated murine macro‐phage inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cellular Immunology 1991; 132: 150–157
   PubMed Web of Science ®Google Scholar
• James S., Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine‐dependent production of reactive nitrogen intermediates. Journal of Immunology 1990; 143: 4208–4212
   Web of Science ®Google Scholar
• Adams H., Hibbs J. J., Jr., Taintor R. R., Krahenbuhl J. L. Microbiostatic effect of murine activated macrophages for toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L‐arginine. Journal of Immunology 1990; 144: 2725–2729
   PubMed Web of Science ®Google Scholar
• Liew F. Y., Millott S., Parkinson C., Palmer R., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L‐arginine. Journal of Immunology 1990; 144: 4794–4797
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Review 1991; 143: 109–142
   Google Scholar
• Liew F. Y., Cox F. E. Nonspecific defence mechanism: the role of nitric oxide. Immunology Today 1991; 6: A17–A21
   Google Scholar
• Scheemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide syn‐thase is not a component of the antimicrobial armature of human mononuclear phagocytes. Journal of Infectious Disease 1993; 167: 1358–1363
   PubMed Web of Science ®Google Scholar
• Mannick J. B., Asano K., Izumi E. K., Stamler J. S. Nitric oxide produced by B lymphocytes inhibits apoptosis and Epstein Barr virus reactivation. Cell 1994; 79: 1137–1146
   PubMed Web of Science ®Google Scholar
• Ouaaz F., Sola B., Issaly F., Kolb J. P., Davi F., Mentz F., Arock M., Paul‐Eughe N., Korner M., Dugas B., Debre P., Mossalayi M. D. Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through litigation of the CD23 surface antigen. Blood 1994; 84: 3095–3104
   PubMed Web of Science ®Google Scholar
• Paul‐Eugéne N., Kolb J. P., Sarfati M., Arock M., Ouaaz F., Debré P., Mossalayi M. D., Dugas B. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L‐arginine‐depen‐dent mechanism. Journal of Leukocyte. Biology 1995; 57: 160–167
   PubMed Web of Science ®Google Scholar
• Vouldoukis I., Riveros‐Moreno V., Dugas B., Ouaaz F., Becherel P., Debré P., Moncada S., Mossalayi M. D. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcϵRII/CD23 surface antigen. Proceedings of the National Academy of Science of the USA 1995; 92: 7804–7808
   PubMed Web of Science ®Google Scholar
• Dugas B., Debre P., Moncada S. Nitric oxide a vital poison inside the immune and inflammatory network. Research in Immunology 1996; 146: 664–670
   Google Scholar
• Paul‐EugGne N., Mossalayi M., Sarfati M., Yamaoka K., Aubry J. P., Bonnefoy J. Y., Dougas B., Kolb J. P. Evidence for a role of FcϵRII/CD23 in the IL‐4‐induced nitric oxide production by normal human mononuclear phagocytes. Cellular Immunology 1995; 163: 314–318
   PubMed Web of Science ®Google Scholar
• Lopez‐Moratalla N., Gonzalez A., Aymerich M. S., Lopez‐Zabalza M. H., Pio R., de Castro P., Santiago E. Monocyte inducible nitric oxide synthase in multiple sclerosis: regulatory role of nitric oxide. Nitric Oxide 1997; 1: 95–104
   PubMed Web of Science ®Google Scholar
• Radi R., Cosgrove T., Beckman J. S., Freeman B. A. Peroxynitrite‐induced luminol chemilumines‐cence. Biochemical Journal 1993; 290: 51–57
   PubMed Web of Science ®Google Scholar
• Catz S. D., Carreras M. C., Poderoso J. J. Nitric oxide synthase inhibitors decrease human poly‐morphonuclear leukocyte luminol‐dependant chemilu‐minescence. Free Radical Biology and Medicine 1995; 19: 741–748
   PubMed Web of Science ®Google Scholar
• Muto S., Sumi K., Inage Y., Matsumoto K., Yuki H. Nitric oxide and immune complexes are involved in the induction of novel luminol chemiluminescence in cytotoxic macrophages. Biological and Pharmacological Bulletin 1996; 19: 1521–1523
   PubMed Web of Science ®Google Scholar
• Dugas N., Mossalayi M. D., Calenda A., Leotard A., Becherel P., Mentz F., Ouaz F., Arock M., Debre P., Domand J., Dugas B. Role of nitric oxide in the antitumoral effect of retinoic acid and 1, 25‐dihydrovitarnin D3 on human promocytic leukemic cells. Blood 1996; 88: 3528–3534
   PubMedGoogle Scholar
• Defacque H., Dornand J., Commes T., Cabane S., Sevilla C., Marti J. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines. Journal of Pharmacological and Experimental Therapeutics 1994; 271: 193–196
   PubMed Web of Science ®Google Scholar
• Caron E., Gross A., Liautard J. P., Dornand J. Brucella species release a specific, protease‐sensitive inhibitor of TNF‐α expression active on human macrophage‐like cells. Journal of Immunology 1996; 257: 2885–2893
   Google Scholar
• Radi R., Rubbio H., Thomson L., Prodanov E. Luminol chemiluminescence using xanthine and hypoxanthine as xanthine oxidase substrates. Free Radical Biology and Medicine 1990; 8: 121–126
   PubMed Web of Science ®Google Scholar
• Taimi M., Defacque H., Commes T., Favero J., Caron E., Marti J. J., Domand J. Effect of retinoic acid and vitamin D on the expression of interleukin‐lg, tumor necrosis factor a and interleukin‐6 in the human monocytic cell line U937. Immunology 1993; 79: 229–235
   PubMed Web of Science ®Google Scholar
• Mozaffarian N., Berman J. W., Casadevall A. Immune complexes increase nitric oxide production by interferon‐γ‐stimulated murine macrophage‐like J774 A. 1 cells. Journal of Leukocyte Biology 1995; 57: 657–662
   PubMed Web of Science ®Google Scholar
• Wang J. F., Komarov P., Sies H., de Groot H. Contribution of nitric oxide synthase to Iuminol‐dependent chemiluminescence generate by phorbol‐ester‐activated Kupffer cells. Biochemical Journal 1991; 279: 311–314
   PubMed Web of Science ®Google Scholar
• Szabo C., Ferrer‐Sueta G., Zingarelli B., Southan G. J., Radi R. Mercaptoethylguanidine and guani‐dine inhibitors of nitric‐oxide synthase react with pero‐xynitrite and protect against peroxinitrite‐induced oxidative damage. Journal of Biological Chemistry 1997; 272: 9030–9036
   PubMed Web of Science ®Google Scholar
• Saran M., Michel C., Bors W. Reaction of 'NO with O2‐‐. Implications for the action of endothe‐lium‐derived relaxing factor(EDRF). Free Radical Research Communication 1990; 10: 221–226
   PubMed Web of Science ®Google Scholar
• Wang J. F., Komarov P., de Groot H. Luminol chemiluminescence in rat macrophages and granulocytes: The role of NO, O2‐/H202 and HOCl. Archives of Biochemistry and Biophysics 1993; 304: 189–196
   PubMed Web of Science ®Google Scholar
• Liochev S. I., Fridovich I. Lucigenin (Bis‐N‐methylacridinium) as a mediator of superoxide anion production. Archives of Biochemisty and Biophysics 1997; 337: 115–120
   PubMed Web of Science ®Google Scholar
• Liochev S. I., Fridovich I. Lucigenin luminescence as a measure of intracellular superoxide dis‐mutase activity in, Escherichia coli. Proceedings of the National Academy of Sciences of the USA 1997; 94: 2891–2896
   PubMed Web of Science ®Google Scholar
• Dumarey C. H., Labrousse V., Rastogi N., Vargaftig B. B., Bachelet M. Selective Mycobacterium avium‐induced production of nitric oxide by human monocyte‐derived macrophages. Journal of Leukocyte Biology 1994; 56: 36–40
   PubMed Web of Science ®Google Scholar
• Bukrinsky M., Nottel H. S. L. M., Schmidtmayerova H., Dubrovsky L., Flanagan C., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV‐1)‐infected monocytes: implications for HIV‐associated neurological disease. Journal of Experimental Medicine 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Evans T. J., Buttery L. D. K., Carpenter A., Springall D. R., Polak J. M., Cohen J. Cytokine‐treated human neutropils contain indicible nitric oxidase that produces nitration of ingested bacteria. Proceedings of the National Academy of Sciences of the USA 1996; 93: 9553–9558
   PubMed Web of Science ®Google Scholar
• Eiserich J. P., Cross C. E., Jones A. D., Halliwell B., van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. Journal of Biological Chemistry 1996; 271: 19199–19208
   PubMed Web of Science ®Google Scholar
• Zhu L., Gunn C., Beckman J. S. Bactericidal activity of peroxynitrite. Archives of Biochemistry and Biophysics 1992; 298: 452–457
   PubMed Web of Science ®Google Scholar